Mackenzie Financial Corp Purchases 33,728 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Mackenzie Financial Corp increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 87.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 72,391 shares of the company's stock after acquiring an additional 33,728 shares during the quarter. Mackenzie Financial Corp owned about 0.06% of Privia Health Group worth $1,415,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of PRVA. Quadrant Capital Group LLC lifted its position in Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after purchasing an additional 511 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Privia Health Group by 8.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock valued at $140,000 after buying an additional 533 shares in the last quarter. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after buying an additional 632 shares in the last quarter. Summit Investment Advisors Inc. lifted its holdings in shares of Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company's stock worth $209,000 after acquiring an additional 678 shares during the period. Finally, WINTON GROUP Ltd boosted its position in shares of Privia Health Group by 1.5% during the 4th quarter. WINTON GROUP Ltd now owns 60,607 shares of the company's stock worth $1,185,000 after acquiring an additional 902 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company's stock.

Insider Transactions at Privia Health Group

In related news, CFO David Mountcastle sold 3,322 shares of Privia Health Group stock in a transaction on Monday, May 12th. The stock was sold at an average price of $24.99, for a total transaction of $83,016.78. Following the sale, the chief financial officer now directly owns 172,909 shares in the company, valued at approximately $4,320,995.91. This trade represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Matthew Shawn Morris sold 10,309 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the sale, the director now directly owns 59,792 shares of the company's stock, valued at approximately $1,394,947.36. This represents a 14.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 51,579 shares of company stock worth $1,226,367 in the last quarter. 10.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on PRVA shares. Barclays boosted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 27th. Robert W. Baird boosted their price target on Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Piper Sandler raised their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. boosted their target price on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 28th. Finally, Truist Financial raised their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group currently has an average rating of "Buy" and an average target price of $27.77.

Privia Health Group Trading Up 0.2%

Shares of NASDAQ:PRVA traded up $0.04 during mid-day trading on Wednesday, hitting $23.01. 694,061 shares of the company traded hands, compared to its average volume of 740,062. The stock has a 50-day moving average price of $23.35 and a two-hundred day moving average price of $22.74. Privia Health Group, Inc. has a 12-month low of $16.37 and a 12-month high of $26.09. The stock has a market cap of $2.81 billion, a P/E ratio of 230.12, a P/E/G ratio of 3.47 and a beta of 0.87.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.